Mitotic counts and Ki-67 values are commonly used to evaluate the proliferative activity of breast cancer, and tumor cell proliferative activity is an important independent prognostic factor in patients with breast cancer [20, 21]. This evidence concerns the gene MKI67 and breast cancer.